Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies

por Rodgers, Thomas D., Casulo, Carla, Boissard, Frederic, Launonen, Aino, Parreira, Joana, Cartron, Guillaume
Publicado 2021

Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia

por Wallace, Danielle S., Zent, Clive S., Baran, Andrea M., Reagan, Patrick M., Casulo, Carla, Rice, Geoffrey, Friedberg, Jonathan W., Barr, Paul M.
Publicado 2023

Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma

por Hume, Kelly R., Sylvester, Skylar R., Borlle, Lucia, Balkman, Cheryl E., McCleary-Wheeler, Angela L., Pulvino, Mary, Casulo, Carla, Zhao, Jiyong
Publicado 2018

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment f...

por Mir, Farheen, Mattiello, Federico, Grigg, Andrew, Herold, Michael, Hiddemann, Wolfgang, Marcus, Robert, Seymour, John F., Bolen, Christopher R., Knapp, Andrea, Nielsen, Tina, Casulo, Carla
Publicado 2020

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders

por Sherazi, Saadia, Schleede, Susan, McNitt, Scott, Casulo, Carla, Moore, Jeremiah E., Storozynsky, Eugene, Patel, Arpan, Vidula, Neelima, Aktas, Mehmet K., Zent, Clive S., Goldenberg, Ilan
Publicado 2023

P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY

por Mehta-Shah, Neha, Jacobsen, Eric, Luigi Zinzani, Pier, Zain, Jasmine, Mead, Monica, Casulo, Carla, Gritti, Giuseppi, Pinter-Brown, Lauren, Izutsu, Koji, Waters, Sheila, Brammer, Jonathan, Pro, Barbara, Horwitz, Steven
Publicado 2023

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline

por Pulvino, Mary, Chen, Luojing, Oleksyn, David, Li, Jing, Compitello, George, Rossi, Randy, Spence, Stephen, Balakrishnan, Vijaya, Jordan, Craig, Poligone, Brian, Casulo, Carla, Burack, Richard, Shapiro, Joel L., Bernstein, Steven, Friedberg, Jonathan W., Deshaies, Raymond J., Land, Hartmut, Zhao, Jiyong
Publicado 2015

Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial

por Casulo, Carla, Santoro, Armando, Cartron, Guillaume, Ando, Kiyoshi, Munoz, Javier, Le Gouill, Steven, Izutsu, Koji, Rule, Simon, Lugtenburg, Pieternella, Ruan, Jia, Arcaini, Luca, Casadebaig, Marie‐Laure, Fox, Brian, Kilavuz, Nurgul, Rettby, Nils, Dell'Aringa, Justine, Taningco, Lilia, Delarue, Richard, Czuczman, Myron, Witzig, Thomas
Publicado 2022

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

por Nowakowski, Grzegorz S., Hong, Fangxin, Scott, David W., Macon, William R., King, Rebecca L., Habermann, Thomas M., Wagner-Johnston, Nina, Casulo, Carla, Wade, James L., Nagargoje, Gauri G., Reynolds, C. M., Cohen, Jonathon B., Khan, Nadia, Amengual, Jennifer E., Richards, Kristy L., Little, R. F., Leonard, John P., Friedberg, Jonathan W., Kostakoglu, Lale, Kahl, Brad S., Witzig, Thomas E.
Publicado 2021

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

por Harkins, R. Andrew, Patel, Sharvil P., Lee, Michelle J., Switchenko, Jeffrey M., Ansell, Stephen M., Bartlett, Nancy L., Blum, Kristie A., Cashen, Amanda F., Casulo, Carla, Friedberg, Jonathan W., Johnston, Patrick B., Kahl, Brad S., Leonard, John P., Link, Brian K., Lossos, Izidore S., Martin, Peter, Maurer, Matt J., Mehta-Shah, Neha, Reagan, Patrick M., Westin, Jason R., Koff, Jean L., Flowers, Christopher R.
Publicado 2022